Conmed (CNMD) Capital Expenditures Growth (1y) (2011 - 2026)
Conmed (CNMD) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -47.73% |
| 10 | Conmed | 1.33 Bn | 1.30 Bn | 183.45 Mn | -23.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.47% |
| Dec 31, 2025 | 26.51% |
| Sep 30, 2025 | 51.71% |
| Jun 30, 2025 | 59.58% |
| Mar 31, 2025 | 85.70% |
| Dec 31, 2024 | -16.79% |
| Sep 30, 2024 | -36.61% |
| Jun 30, 2024 | -20.73% |
| Mar 31, 2024 | -52.16% |
| Dec 31, 2023 | -14.46% |
| Sep 30, 2023 | -19.62% |
| Jun 30, 2023 | -20.70% |
| Mar 31, 2023 | 15.38% |
| Dec 31, 2022 | 78.04% |
| Sep 30, 2022 | 20.38% |
| Jun 30, 2022 | 90.75% |
| Mar 31, 2022 | 18.59% |
| Dec 31, 2021 | 1.24% |
| Sep 30, 2021 | 69.61% |
| Jun 30, 2021 | -20.20% |